Although the role of ZIP9 in breast cancers is unclear, ZIP9 is overexpressed in breast carcinoma tissues and predicts worse prognoses in HER2-type breast cancers (Liu et al. 2020). This evidence concerns the gene ERBB2 and breast carcinoma.